Ophthalmo-Framykoin (Bacitracin Zinc, Neomycin Sulfate)

Ophthalmo-Framykoin, containing bacitracin zinc and neomycin sulfate, is used to manage bacterial infections of the eye.

• Conjunctivitis: reduces bacterial load and alleviates redness and discharge.
• Blepharitis: treats the bacterial component of eyelid inflammation.
• Corneal ulcer (superficial): helps prevent bacterial proliferation and promotes healing.
• Post‑operative ocular prophylaxis: prevents infection after eye surgery.

• Bacitracin zinc interferes with bacterial cell‑wall synthesis by binding to the C55 lipid carrier, while neomycin sulfate binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibition of protein synthesis. The combined actions provide broad‑spectrum antibacterial activity against Gram‑positive and Gram‑negative ocular pathogens.

Common Side Effects

• Eye irritation: mild burning or stinging sensation.
• Redness: transient conjunctival hyperemia.
• Itching: localized pruritus around the application site.
• Temporary blurred vision: resolves after a few minutes.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): swelling, difficulty breathing.
• Corneal ulcer worsening: increased pain or vision loss.
• Stevens‑Johnson syndrome: widespread skin and mucous membrane lesions.
• Toxic keratitis: persistent corneal inflammation.
• Persistent ocular pain: may indicate deeper infection.
• Vision loss: rare but requires immediate medical attention.

Before using Ophthalmo-Framykoin, consider the following precautions:

• Allergy assessment: verify no known hypersensitivity to bacitracin, neomycin or related antibiotics.
• Contact lens use: avoid wearing lenses during treatment or remove them before application.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk.
• Pediatric use: safety in newborns and infants has not been fully established.
• Systemic absorption: monitor renal function in patients with existing kidney impairment.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Ophthalmo-Framykoin may interact with other medicines as follows:

Major Interactions (Avoid)

• Aminoglycoside ototoxic drugs: increased risk of ear toxicity.
• Systemic nephrotoxic agents: potential additive renal toxicity.
• Topical ophthalmic steroids: may reduce antibacterial efficacy.

Moderate Interactions (Monitor Closely)

• Anticholinergic eye drops: may affect ocular surface tolerance.
• Other topical antibiotics: risk of antagonistic effects.
• Contact lens solutions containing preservatives: may cause irritation.